Deconvolution of transcriptomes and miRNomes by independent component analysis provides insights into biological processes and clinical outcomes of melanoma patients
Abstract Background The amount of publicly available cancer-related "omics" data is constantly growing and can potentially be used to gain insights into the tumour biology of new cancer patients, their diagnosis and suitable treatment options. However, the integration of different datasets...
Saved in:
Main Authors: | Petr V. Nazarov (Author), Anke K. Wienecke-Baldacchino (Author), Andrei Zinovyev (Author), Urszula Czerwińska (Author), Arnaud Muller (Author), Dorothée Nashan (Author), Gunnar Dittmar (Author), Francisco Azuaje (Author), Stephanie Kreis (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments
by: Eloy Almenar-Pérez, et al.
Published: (2019) -
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
by: Vicente Herrero-Aguayo, et al.
Published: (2022) -
Resveratrol Treatment Induces Mito-miRNome Modification in Follicular Fluid from Aged Women with a Poor Prognosis for In Vitro Fertilization Cycles
by: Rosalia Battaglia, et al.
Published: (2022) -
Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line
by: Haruto Uchino, et al.
Published: (2018) -
miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool
by: María Sol Ruiz, et al.
Published: (2021)